0001494650-19-000031.txt : 20190306
0001494650-19-000031.hdr.sgml : 20190306
20190306182950
ACCESSION NUMBER: 0001494650-19-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gibbs Thomas Edward
CENTRAL INDEX KEY: 0001639012
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38241
FILM NUMBER: 19663795
MAIL ADDRESS:
STREET 1: 2200 PENNSYLVANIA AVENUE NW
STREET 2: SUITE 300E
CITY: WASHINGTON
STATE: DC
ZIP: 20037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptiNose, Inc.
CENTRAL INDEX KEY: 0001494650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421771610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 267-364-3500
MAIL ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
4
1
wf-form4_155191497668547.xml
FORM 4
X0306
4
2019-02-28
0
0001494650
OptiNose, Inc.
OPTN
0001639012
Gibbs Thomas Edward
C/O OPTINOSE, INC.
1020 STONY HILL ROAD, SUITE 300
YARDLEY
PA
19067
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
7.42
2019-02-28
4
A
0
82500
0
A
2029-02-28
Common Stock
82500.0
82500
D
The option vests and becomes exercisable over a four-year period commencing on February 28, 2019. Twenty-five percent (25%) of the option vests and becomes exercisable on February 28, 2020, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.
/s/ Leanne Kelly, attorney-in-fact
2019-03-06